SBCM
APYX icon

Silverberg Bernstein Capital Management’s Apyx Medical APYX Stock Holding History

Silverberg Bernstein Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.67M Sell
1,039,641
-1,429
-0.1% -$5.67K 1.79% 15
2026
Q1 		$3.84M Buy
1,041,070
+8,067
+0.8% +$30.1K 2.12% 12
2025
Q4 		$3.62M Buy
1,033,003
+46,500
+5% +$162K 2.09% 14
2025
Q3 		$2.11M Buy
986,503
+89,767
+10% +$190K 1.28% 21
2025
Q2 		$2.02M Buy
896,736
+250,167
+39% +$352K 1.38% 19
2025
Q1 		$886K Buy
646,569
+75,337
+13% +$104K 0.82% 32
2024
Q4 		$903K Sell
571,232
-1,400
-0.2% -$1.96K 0.79% 29
2024
Q3 		$710K Sell
572,632
-23,855
-4% -$30.1K 0.65% 34
2024
Q2 		$799K Sell
596,487
-24,900
-4% -$36.7K 0.77% 30
2024
Q1 		$845K Buy
621,387
+7,507
+1% +$16K 0.83% 30
2023
Q4 		$1.61M Buy
+613,880
New +$1.49M 1.53% 15

Other funds holding APYX

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Silverberg Bernstein Capital Management's APYX Position: Q2 2026 in Review

Silverberg Bernstein Capital Management reduced its Apyx Medical (APYX) stake by 0.14% in Q2 2026, selling an estimated $5.67K and leaving 1,039,641 shares worth $4.67M. The position accounts for 1.79% of the portfolio, ranked #15.

Silverberg Bernstein Capital Management first reported a position in APYX in Q4 2023 and has held it in 11 quarters since. 9 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Silverberg Bernstein Capital Management held 1,039,641 shares of Apyx Medical worth $4.67M as of Q2 2026.
  • Silverberg Bernstein Capital Management sold 1,429 Apyx Medical shares in Q2 2026, an estimated $5.67K.
  • Apyx Medical made up 1.79% of Silverberg Bernstein Capital Management's portfolio in Q2 2026, its #15 holding.
  • Silverberg Bernstein Capital Management first reported a position in Apyx Medical in Q4 2023 and has held it in 11 quarters since.
  • 9 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Silverberg Bernstein Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.